TrialFrontiers in immunology2021

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.

André Santa Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.